
Endocrinology company Valendo Health launches with $4M and two provider partners
Valendo Health, a diabetes-focused endocrinology company, has launched with $4 million in seed funding and two providers. The company, part of Redesign Health, aims to increase revenue for endocrinologists and assist with the transition to a value-based care model. It offers telehealth and remote patient monitoring services, an endocrinology-focused EMR, data analytics, and help with…